BCM
AVNS

BlueCrest Capital Management’s Avanos Medical AVNS Stock Holding History

BlueCrest Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,880
Closed -$781K – 784
2015
Q1 		$781K Buy
+15,880
New +$736K 0.04% 394

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlueCrest Capital Management's AVNS Position: Q2 2015 in Review

BlueCrest Capital Management sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 15,880 shares — an estimated $781K sold.

BlueCrest Capital Management first reported a position in AVNS in Q1 2015 and held it in 1 quarter. The position peaked at $781K in Q1 2015. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • BlueCrest Capital Management reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 15,880 Avanos Medical shares in Q2 2015, an estimated $781K.
  • BlueCrest Capital Management first reported a position in Avanos Medical in Q1 2015 and held it in 1 quarter.
  • BlueCrest Capital Management's Avanos Medical position peaked at $781K in Q1 2015.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on BlueCrest Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.